Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Featured Image
Read the Original
This page is a summary of: Is the light at the end of the tunnel nigh? A review of ADPKD focusing on the burden of disease and tolvaptan as a new treatment, International Journal of Nephrology and Renovascular Disease, February 2018, Dove Medical Press,
DOI: 10.2147/ijnrd.s136359.
You can read the full text:
Contributors
The following have contributed to this page
